Cargando…
The Mechanism of Osteoprotegerin-Induced Osteoclast Pyroptosis In Vitro
Osteoprotegerin (OPG) is a new member of the tumor necrosis factor (TNF) receptor superfamily, which can inhibit the differentiation and activity of osteoclasts by binding to nuclear factor kappa B receptor activator (RANK) competitively with nuclear factor kappa B receptor activator ligand (RANKL)....
Autores principales: | Zhu, Jiaqiao, Ma, Yonggang, Wang, Jie, Wang, Yangyang, Ali, Waseem, Zou, Hui, Zhao, Hongyan, Tong, Xishuai, Song, Ruilong, Liu, Zongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861131/ https://www.ncbi.nlm.nih.gov/pubmed/36675029 http://dx.doi.org/10.3390/ijms24021518 |
Ejemplares similares
-
Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling
por: Ma, Yonggang, et al.
Publicado: (2022) -
Suppression of AMP‐activated protein kinase reverses osteoprotegerin‐induced inhibition of osteoclast differentiation by reducing autophagy
por: Tong, Xishuai, et al.
Publicado: (2019) -
Overexpression of c‐Fos reverses osteoprotegerin‐mediated suppression of osteoclastogenesis by increasing the Beclin1‐induced autophagy
por: Tong, Xishuai, et al.
Publicado: (2020) -
Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway
por: Liu, Wei, et al.
Publicado: (2015) -
P2X7 receptor knockdown suppresses osteoclast differentiation by inhibiting autophagy and Ca(2+)/calcineurin signaling
por: Ma, Yonggang, et al.
Publicado: (2022)